Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and caprylates

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with caprylates in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(caprylates)
Trials
(caprylates)
Recent Studies (post-2010) (caprylates)
9,1561875525,0611002,339

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carpentier, Y; De Vriese, C; Delporte, C; Gregoire, F; Hacquebard, M1
Greiner, C; Hörnig, C; Pergola, C; Rossi, A; Sautebin, L; Schubert-Zsilavecz, M; Steinhilber, D; Werz, O; Zettl, H1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and caprylates

ArticleYear
Ghrelin interacts with human plasma lipoproteins.
    Endocrinology, 2007, Volume: 148, Issue:5

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acylation; Adult; Butyrylcholinesterase; Caprylates; Chromatography, Affinity; Enzyme Inhibitors; Female; Ghrelin; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Peptide Hormones; Platelet Activating Factor; Protein Structure, Tertiary; Triglycerides

2007
2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo.
    British journal of pharmacology, 2011, Volume: 164, Issue:2b

    Topics: Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Caprylates; Carrageenan; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mice; Neutrophils; Nuclear Envelope; Platelet Activating Factor; Pleurisy; Protein Transport; Pyrimidines; Rats; Rats, Wistar; Shock

2011